AronPharma’s Study on Liposomal Vitamin C in Powder Form Published in Applied Sciences

Research Confirms Enhanced Absorption of Liposomal Vitamin C Powder Produced in Innovative Organic Solvent-Free Process with Maltodextrin Coating

[Gdańsk, 4 Sept 2024] — AronPharma is excited to announce the recent publication of a study on liposomal vitamin C in powder form, highlighting its enhanced bioavailability and stability. The study, published in the prestigious journal Applied Sciences, presents key findings that could redefine the food supplement industry.

Study Design and Key Findings 

The study employed a randomized, double-blind, cross-over design to evaluate the efficacy of liposomal vitamin C in a powder form. Key findings from the study demonstrate that liposomal vitamin C increases plasma vitamin C levels up to 30% AUC (area under the curve, representing the total absorbed dose of vitamin C) compared to conventional vitamin C formulations, showcasing improved absorption and sustained release. 

Furthermore, the research indicates that the spray drying does not have negative impact on the properties and pharmacokinetic profile of the obtained liposomal vitamin C powder, which may extend the shelf-life and efficacy of the final product. 

Innovative Preparation Process 

A hallmark of liposomal vitamin C studied in AronPharma’s laboratory is the innovative preparation process that eliminates the use of organic solvents. This method ensures that the liposomes are both environmentally friendly and safe for consumers.  

The process involves encapsulating vitamin C in liposomes—small, spherical vesicles that protect the nutrient and enhance its delivery into the cells. Liposomes are further coated with a maltodextrin shell. The carbohydrate shell enhances the stability of the vitamin C, resulting in a product that offers superior bioavailability while maintaining the integrity of the vitamin C. 

Barbara Khaidakov, Ph.D. Head of R&D at AronPharma, AronPharma

Barbara Khaidakov, Head of Research and Development at AronPharma, remarked, “This publication marks a significant milestone in our mission to advance health and wellness through cutting-edge science. Our solvent-free preparation of liposomal vitamin C with maltodextrin coating underscores our commitment to sustainability and delivers a product that meets the highest standards of efficacy. We are proud to offer a solution that empowers individuals to take control of their health with confidence.” 

 

For more detailed insights, access the full study here. 

 

About liposomal vitamin C 

Liposomal vitamin C (Liposovit®-C), we tested on Caco-2 cells and included in the Lipo4UTM product line, is a part of Bart Ltd. Portfolio. A cutting-edge food supplement designed for superior absorption and stability. Unlike traditional supplements, it uses liposome technology to encapsulate vitamin C, protecting it from degradation and enhancing its delivery into the bloodstream.  

Prepared through organic solvent-free process with a maltodextrin shell formulation ensures higher bioavailability and prolonged effectiveness. 

About AronPharma 

AronPharma is a leading innovator in the field of nutraceuticals, dedicated to developing high-quality supplements based on the latest scientific research. Our mission is to enhance well-being through innovative solutions that combine efficacy, safety, and sustainability. 

 

 

 

Media & Marketing Contact:

Małgorzata Gromadzka 

malgorzata.gromadzka@aronpharma.pl